- Country: USA
- Summary: Dallas Pharmacy Compounding Services Oncology Drugs
- UST Ref No: 123175351
- Deadline: 25 Aug 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 36C25725Q0787
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Description
The Department of Veterans Affairs, Veterans Health Administration, Veterans Integrated Service Network (VISN) 17, Network Contracting Office 17 (NCO17) is seeking sources for the following procurement: Dallas Pharmacy Compounding Oncology Drug. Note: This is an FY26 requirement, to be awarded by 11/1/2025.NAICS: 325412PSC: Q517Delivery Location: Dallas VA Medical Center4500 S Lancaster RDDallas, TX 75216PLEASE PROVIDE ANSWERS WITH YOUR RESPONSE TO THE FOLLOWING: Company Size: example: Large, Small? Is your company the manufacturer of the items being requested? Does your company exceed 500 employees? Is your company engaged in the retail or wholesale trade and normally sells the type of item being supplied/requested? Does your company take ownership or possession of the item(s) with its personnel, equipment or facilities in a manner consistent with industry practice? and Will supply the end item of a small business manufacturer? This notice is NOT a formal request for quote or proposals. No formal solicitation document exists at this time. The information in this notice is for information and planning purposes only and is not to be construed as a commitment by the government. No contract will be awarded from this notice. Interested firms must respond directly to the POC email address listed in the notice for consideration. POC: jennifer.stringer@va.gov .Statement of WorkPharmacy Services Procurement of hazardous sterile compounded productsINTRODUCTIONThe Contractor shall provide chemotherapy preparation services for patient use for the VA North Texas Healthcare System. The contractor must be a U.S. based company capable of providing chemotherapy preparation in CETA CAG certified primary engineering control and secondary engineering control environment. The contractor must be able to provide next day delivery of compounded chemotherapy preparations. 1.2. This contract is for non-personal services. It does not create employment rights with the U.S.Gove... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINDallas Pharmacy Compounding Services Oncology Drugs - USA Tender
The VETERANS AFFAIRS, DEPARTMENT OF, a Government sector organization in USA, has announced a new tender for Dallas Pharmacy Compounding Services Oncology Drugs. This tender is published on USARFP under UST Ref No: 123175351 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-08-25.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
